Advances in Molecular Research of Leukaemia
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (20 November 2023) | Viewed by 313
Special Issue Editors
Interests: acute myeloid leukemia; chronic lymphocytic leukemia
Special Issues, Collections and Topics in MDPI journals
Interests: chronic lymphocytic leukaemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Leukemias are heterogeneous and biologically complex blood malignancies affecting people from childhood to old age with various clinical outcomes.
Over the last few decades, the dissection of leukemia pathogenetic mechanisms has led to the identification of the role of recurrent mutations, epigenetic alterations and the aberrant activation of oncogenic signaling. A better understanding of leukemogenesis has allowed precision medicine to radically transform diagnostic and therapeutic approaches, thus greatly improving the outcomes of patients with hematological malignancies, but not for all subtypes.
The aim of this Special Issue is to delve into the continuously expanding field of molecular research on leukemia in both the diagnostic and therapeutic field.
The final purpose is to provide precious translational clues that can help to face yet unmet clinical needs.
Studies about molecular biomarkers related to the pathogenesis, diagnosis, prognosis, new therapeutic opportunities and treatment resistance of leukemias are welcome.
Dr. Daniele Sorcini
Dr. Filomena De Falco
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- leukemia
- epigenetic deregulation
- gene mutation
- biomarkers
- leukemogenesis
- precision medicine
- drug resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
